Semnur Pharmaceuticals, Inc. (SMNR)

Semnur Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	2,632	39	72	111
Market Cap Growth	2137.57%	-45.38%	-35.07%	-
Enterprise Value	2,684	77	-	-
Last Close Price	9.00	11.88	10.17	10.29
PB Ratio	-59.22	-0.92	-1.90	-3.20
Debt / Equity Ratio	-1.17	-1.15	-0.99	-1.02
Quick Ratio	0.04	0.34	0.01	0.14
Current Ratio	6.19	171.29	0.02	0.37
Return on Assets (ROA)	-	-79.36%	-278.24%	-
Return on Capital (ROIC)	-	-90.81%	-1089.91%	-
Earnings Yield	-0.14%	-11.88%	-4.51%	-3.38%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.